Medical Science at the Forefront of Russia’s Technological Sovereignty
On the first day of the 2nd National Congress with international participation “National Healthcare 2023”, an expert session will be held on the development of medical science in Russia as a means to achieving the country’s technological sovereignty. The Congress is being organized by the Russian Ministry of Health and the Roscongress Foundation. The organizing partner of the event is the Russian Research Institute of Health of the Russian Ministry of Health. The Congress will take place at the International RUSSIA EXPO at VDNH on 1–2 December 2023.
The rapid development of medical science in Russia is contributing to significant achievements in the medical and pharmaceutical industries, improving genomic technologies and the production of innovative drugs, and creating unparalleled medical technologies and equipment. However, to achieve technological sovereignty in the healthcare industry, it is crucial to enhance the level of interaction between the scientific community, government, and business and prioritize areas of focus and projects that aim to create a specific tangible and practice-oriented result or product that is promising in terms of industrial production and its introduction in clinical practice. Implementing these ambitious goals will help achieve the strategic goals of reducing dependence on imports, modernizing Russia’s domestic production capacities, and ensuring a consistently high level of national healthcare regardless of external factors.
“Today, comprehensive support for medical science – both applied and fundamental research – plays a critical role. The priority is to increase the number of medical and pharmaceutical developments that are entirely our own, intensify technology transfers, and shorten the path from a scientific breakthrough to the incorporation of its results in medical practice,” Academician and Secretary of the Department of Medical Sciences of the Russian Academy of Sciences Vladimir Starodubov said.
Some of the key questions that the discussion participants will address include: what areas of medical science should be regarded as the top priorities and the most promising, how do developments with AI affect the development of the healthcare system, what government incentives are needed right now to get the scientific community and the medical and pharmaceutical industries completely focused on ensuring technological sovereignty in the healthcare sector?
The 2nd National Congress with international participation “National Healthcare 2023” will bring together representatives of the federal and regional authorities, industry leaders, foreign experts, strategic partners, and members of the business community who support the global social mission of protecting the health of the Russian population.
Official website of the event: nzdrav.ru.